The U.S. The Food and Drug Administration (FDA) states its purpose in the following equipment statement: “The FDA has a responsibility to protect public health by ensuring the safety, efficacy, and safety of human and animal drugs, biological products, medical devices, food of our country, cosmetics, and radiation products.
The FDA is also responsible for improving public health by helping to speed up the development of new products that make medicines and foods more effective, safer, and less expensive; and to help the public acquire the accurate, scientific knowledge they need to use medicine and food to improve their health.
” In 2005 the FDA issued a draft public guideline document to the pharmaceutical industry regarding the development of a treatment for acne vulgaris, or acne. The draft guideline document contains the FDA's current thinking on the development of acne medications and the methods to be used. More information on the guide document is summarized below. At the time of writing this FDA document has not been finalized.
Types of Acne The two main types of acne ulcers are classified as non-inflamed and inflamed. Non-swollen acne sores are often called whiteheads and blackheads. Inflammatory acne sores include papules and pustules and are located deeper in the skin than non-inflamed sores. How Acne Acne Is Measured There is currently no set way to quantify the severity of acne.
There are several proposed methods, but each has its own set of difficulties. A sample scale to measure acne hardness is summarized below, from the smallest to the worst: 0 Clean skin with no swollen or non-swollen sores 1 Almost clear; rare non-inflammatory ulcers with less than one inflammation 2 Slight stiffness; greater than
Grade1; other non-inflammatory lesions with inflammatory lesions (papules / pustules only, nodular lesions)3 Medium strength; greater than
Grade 2; many non-swollen sores and may have swollen sores, but not more than one small sores ulcer
4 * Very; greater than
Grade 3; up to many non-swollen and inflamed sores, but not more than a few nodular sores (* possibly beyond Grade 4). Acne Treatment Groups Forensic drug testing teams should be large enough to be statistically significant so that any claims for success and safety are supported.
Experimental patients are often hired during an outbreak of severe acne. Acupuncture medications are recommended to be randomly assigned, blinded, multidisciplinary tests, and other requirements will also apply. The control or placebo group should be used. In addition, those conducting the study should hire testing people who represent the age, race, gender, and location of acne patients in the United States.
Determining the Success of Acne Treatment Acne scores are measured at the beginning and end of each test. Photographic and / or statistical evidence of wounds may also be taken. It is proposed to measure the success of acne medications as a success or failure, based on one of the two methods of measuring success:
1. Success means a clear or almost clear skin (weight scale 0 or 1) during the test period; or 2. Success means the development of 2 grades during the test period. Under this definition, a successful experimental study may have a weight gain from 4 to 2 during the test period, for example.
Final Decision on New Acne Drugs Several stages of testing for the recommended acne treatment are recommended. Courses should be designed to look at outcomes such as dropping out of a test. Strict data analysis should be done in accordance with FDA regulations.
Only acne drug testing data is validated and tested for quality assurance that must be submitted to the FDA for approval. Only through a strict and strictly regulated testing and evaluation process, followed by FDA approval, can new prescription drugs be made available to the public.
The resource link below contains free information on the best ways to use FDA-approved prescription and over-the-counter medications and treatments. Source: Industrial Guidelines, Acne Vulgaris: Drug Development Drugs, DRAFT 2, U.S. Department of Health and Human Services, Food and Drug Administration Research and Research Institute (CDER), September 2005, Clinical / Medical.
You must be logged in to post a comment.